Concepts (300)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 13 | 2025 | 264 | 3.470 |
Why?
|
| Knee Joint | 19 | 2025 | 284 | 3.380 |
Why?
|
| Hip Prosthesis | 21 | 2021 | 248 | 3.340 |
Why?
|
| Gait | 15 | 2025 | 195 | 2.730 |
Why?
|
| Arthroplasty, Replacement, Hip | 16 | 2021 | 349 | 2.540 |
Why?
|
| Nanotubes | 3 | 2025 | 13 | 2.530 |
Why?
|
| Prosthesis Failure | 19 | 2021 | 229 | 2.400 |
Why?
|
| Polyethylene | 12 | 2020 | 52 | 2.310 |
Why?
|
| Cartilage, Articular | 11 | 2020 | 163 | 2.000 |
Why?
|
| Titanium | 10 | 2025 | 99 | 2.000 |
Why?
|
| Anti-Bacterial Agents | 3 | 2025 | 207 | 1.710 |
Why?
|
| Prosthesis-Related Infections | 3 | 2024 | 98 | 1.540 |
Why?
|
| Biomechanical Phenomena | 20 | 2022 | 297 | 1.530 |
Why?
|
| Biocompatible Materials | 5 | 2020 | 42 | 1.530 |
Why?
|
| Tibia | 7 | 2022 | 100 | 1.510 |
Why?
|
| Knee Prosthesis | 8 | 2020 | 92 | 1.490 |
Why?
|
| Alloys | 8 | 2025 | 51 | 1.460 |
Why?
|
| Osteoarthritis, Knee | 8 | 2025 | 169 | 1.380 |
Why?
|
| Joint Prosthesis | 2 | 2024 | 43 | 1.370 |
Why?
|
| Walking | 5 | 2022 | 108 | 1.370 |
Why?
|
| Gentamicins | 3 | 2025 | 17 | 1.280 |
Why?
|
| Humans | 63 | 2025 | 12240 | 1.280 |
Why?
|
| Chitosan | 3 | 2025 | 12 | 1.220 |
Why?
|
| Hip Joint | 8 | 2016 | 136 | 1.110 |
Why?
|
| Range of Motion, Articular | 8 | 2019 | 278 | 1.070 |
Why?
|
| Middle Aged | 29 | 2025 | 4043 | 1.060 |
Why?
|
| Osseointegration | 2 | 2025 | 53 | 1.060 |
Why?
|
| Prostheses and Implants | 4 | 2025 | 92 | 1.040 |
Why?
|
| Joint Instability | 2 | 2025 | 145 | 1.020 |
Why?
|
| Male | 31 | 2025 | 6815 | 1.020 |
Why?
|
| Steel | 2 | 2020 | 2 | 1.010 |
Why?
|
| Aged | 26 | 2025 | 4000 | 0.970 |
Why?
|
| Aluminum Oxide | 2 | 2019 | 3 | 0.950 |
Why?
|
| Prosthesis Design | 14 | 2021 | 195 | 0.910 |
Why?
|
| Machine Learning | 1 | 2025 | 31 | 0.860 |
Why?
|
| Nickel | 2 | 2021 | 15 | 0.850 |
Why?
|
| Female | 29 | 2025 | 6974 | 0.840 |
Why?
|
| Metals | 5 | 2017 | 56 | 0.820 |
Why?
|
| Polyethylenes | 5 | 2018 | 18 | 0.820 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 81 | 0.820 |
Why?
|
| Stress, Mechanical | 13 | 2020 | 86 | 0.780 |
Why?
|
| Materials Testing | 11 | 2021 | 70 | 0.710 |
Why?
|
| Aged, 80 and over | 15 | 2019 | 2152 | 0.640 |
Why?
|
| Osteoarthritis, Hip | 5 | 2014 | 38 | 0.630 |
Why?
|
| Femur | 4 | 2019 | 190 | 0.620 |
Why?
|
| Corrosion | 9 | 2021 | 54 | 0.600 |
Why?
|
| Ankle Injuries | 3 | 2016 | 7 | 0.590 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2009 | 6 | 0.590 |
Why?
|
| Postoperative Complications | 4 | 2017 | 385 | 0.580 |
Why?
|
| Arthroplasty, Replacement, Ankle | 1 | 2018 | 2 | 0.560 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2018 | 76 | 0.560 |
Why?
|
| Vitallium | 3 | 2013 | 15 | 0.540 |
Why?
|
| Animals | 12 | 2025 | 2092 | 0.540 |
Why?
|
| Models, Biological | 4 | 2018 | 191 | 0.540 |
Why?
|
| Proteoglycans | 3 | 2017 | 59 | 0.530 |
Why?
|
| Surface Properties | 13 | 2021 | 66 | 0.490 |
Why?
|
| Joints | 2 | 2016 | 43 | 0.470 |
Why?
|
| Walking Speed | 1 | 2016 | 13 | 0.470 |
Why?
|
| Adult | 15 | 2017 | 3557 | 0.460 |
Why?
|
| Cartilage | 2 | 2019 | 41 | 0.460 |
Why?
|
| Weight-Bearing | 10 | 2020 | 72 | 0.460 |
Why?
|
| Staphylococcus aureus | 2 | 2025 | 36 | 0.440 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 423 | 0.430 |
Why?
|
| Chondrocytes | 5 | 2015 | 58 | 0.420 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 182 | 0.420 |
Why?
|
| Hyperkinesis | 1 | 2013 | 8 | 0.400 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2013 | 10 | 0.400 |
Why?
|
| Treatment Outcome | 9 | 2024 | 1478 | 0.390 |
Why?
|
| Device Removal | 5 | 2016 | 32 | 0.370 |
Why?
|
| Mouth | 1 | 2012 | 5 | 0.370 |
Why?
|
| Dental Implants | 1 | 2012 | 5 | 0.370 |
Why?
|
| Fragile X Syndrome | 1 | 2013 | 140 | 0.350 |
Why?
|
| Acetabulum | 3 | 2007 | 81 | 0.330 |
Why?
|
| Radiography | 5 | 2014 | 258 | 0.310 |
Why?
|
| Risk Factors | 6 | 2017 | 1049 | 0.310 |
Why?
|
| Equipment Failure Analysis | 8 | 2012 | 32 | 0.310 |
Why?
|
| Zirconium | 2 | 2019 | 3 | 0.310 |
Why?
|
| Microscopy, Electron, Scanning | 7 | 2013 | 48 | 0.290 |
Why?
|
| Bioreactors | 3 | 2006 | 3 | 0.290 |
Why?
|
| Anterior Cruciate Ligament Injuries | 2 | 2022 | 80 | 0.290 |
Why?
|
| Keratinocytes | 1 | 2008 | 4 | 0.280 |
Why?
|
| Reoperation | 6 | 2014 | 366 | 0.280 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2008 | 3 | 0.280 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 19 | 0.280 |
Why?
|
| Cell Culture Techniques | 3 | 2006 | 14 | 0.280 |
Why?
|
| Stromal Cells | 1 | 2008 | 21 | 0.280 |
Why?
|
| Skin Neoplasms | 1 | 2008 | 30 | 0.280 |
Why?
|
| Friction | 5 | 2020 | 10 | 0.280 |
Why?
|
| Synovial Fluid | 3 | 2021 | 53 | 0.280 |
Why?
|
| Shoes | 2 | 2022 | 13 | 0.270 |
Why?
|
| Pressure | 3 | 2020 | 24 | 0.270 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2008 | 70 | 0.270 |
Why?
|
| Nitrogen | 2 | 2021 | 2 | 0.260 |
Why?
|
| Mice | 2 | 2025 | 760 | 0.250 |
Why?
|
| Osteoarthritis | 2 | 2022 | 168 | 0.250 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2006 | 22 | 0.240 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2021 | 81 | 0.240 |
Why?
|
| Exercise Test | 1 | 2006 | 62 | 0.240 |
Why?
|
| Stainless Steel | 2 | 2021 | 8 | 0.230 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2025 | 21 | 0.230 |
Why?
|
| Tissue Engineering | 2 | 2006 | 16 | 0.230 |
Why?
|
| Hyaluronic Acid | 2 | 2021 | 23 | 0.230 |
Why?
|
| Cluster Analysis | 1 | 2025 | 23 | 0.220 |
Why?
|
| Electroplating | 1 | 2024 | 3 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 205 | 0.220 |
Why?
|
| Time Factors | 8 | 2016 | 695 | 0.220 |
Why?
|
| Microscopy, Electron, Transmission | 4 | 2013 | 14 | 0.220 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2004 | 3 | 0.210 |
Why?
|
| Brain | 1 | 2009 | 707 | 0.210 |
Why?
|
| Ankle Joint | 3 | 2016 | 21 | 0.210 |
Why?
|
| In Vitro Techniques | 2 | 2016 | 117 | 0.200 |
Why?
|
| Dental Alloys | 2 | 2013 | 2 | 0.190 |
Why?
|
| Ceramics | 2 | 2019 | 3 | 0.180 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 726 | 0.180 |
Why?
|
| Inflammation | 2 | 2020 | 124 | 0.170 |
Why?
|
| Movement | 3 | 2013 | 58 | 0.170 |
Why?
|
| Electromyography | 2 | 2018 | 22 | 0.170 |
Why?
|
| Implants, Experimental | 1 | 2021 | 28 | 0.170 |
Why?
|
| Muscle Strength | 3 | 2019 | 46 | 0.160 |
Why?
|
| Risk Assessment | 2 | 2012 | 295 | 0.160 |
Why?
|
| Recovery of Function | 2 | 2011 | 118 | 0.160 |
Why?
|
| Mass Spectrometry | 1 | 2000 | 16 | 0.150 |
Why?
|
| Cattle | 5 | 2020 | 54 | 0.150 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2000 | 16 | 0.150 |
Why?
|
| Reference Values | 2 | 2017 | 103 | 0.150 |
Why?
|
| Electrochemistry | 3 | 2017 | 29 | 0.150 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 171 | 0.140 |
Why?
|
| Body Mass Index | 2 | 2018 | 221 | 0.140 |
Why?
|
| Bone Density | 2 | 2011 | 110 | 0.140 |
Why?
|
| Equipment Design | 3 | 2012 | 76 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2017 | 44 | 0.130 |
Why?
|
| Bone Cements | 2 | 2012 | 37 | 0.130 |
Why?
|
| Stair Climbing | 1 | 2017 | 5 | 0.130 |
Why?
|
| Cell Survival | 1 | 2017 | 46 | 0.130 |
Why?
|
| Cadaver | 3 | 2022 | 166 | 0.120 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 93 | 0.120 |
Why?
|
| Metal-on-Metal Joint Prostheses | 2 | 2014 | 14 | 0.120 |
Why?
|
| Allografts | 1 | 2017 | 74 | 0.120 |
Why?
|
| Cytokines | 1 | 2017 | 107 | 0.120 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 201 | 0.120 |
Why?
|
| Chromium | 3 | 2016 | 35 | 0.120 |
Why?
|
| Hamstring Muscles | 1 | 2016 | 12 | 0.120 |
Why?
|
| Cobalt | 3 | 2016 | 46 | 0.120 |
Why?
|
| Genome, Human | 1 | 2015 | 21 | 0.110 |
Why?
|
| Saliva, Artificial | 2 | 2013 | 2 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 37 | 0.110 |
Why?
|
| Autopsy | 1 | 2016 | 174 | 0.110 |
Why?
|
| Gene Expression | 1 | 2015 | 97 | 0.110 |
Why?
|
| Osteolysis | 1 | 2016 | 66 | 0.110 |
Why?
|
| Knee | 2 | 2017 | 16 | 0.110 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 1 | 2016 | 70 | 0.110 |
Why?
|
| Quadriceps Muscle | 2 | 2016 | 16 | 0.110 |
Why?
|
| Proprioception | 1 | 2014 | 8 | 0.110 |
Why?
|
| Age Factors | 1 | 2016 | 350 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 60 | 0.110 |
Why?
|
| Young Adult | 2 | 2016 | 863 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2009 | 157 | 0.100 |
Why?
|
| Dental Materials | 1 | 2013 | 3 | 0.100 |
Why?
|
| Physical Examination | 1 | 2014 | 37 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 27 | 0.100 |
Why?
|
| Escherichia coli | 1 | 2013 | 18 | 0.100 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 41 | 0.100 |
Why?
|
| Spectrum Analysis | 2 | 2010 | 5 | 0.100 |
Why?
|
| Foot Orthoses | 1 | 2013 | 5 | 0.100 |
Why?
|
| Bone Malalignment | 1 | 2013 | 5 | 0.100 |
Why?
|
| Algorithms | 1 | 2014 | 169 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 125 | 0.090 |
Why?
|
| Apoptosis | 2 | 2010 | 105 | 0.090 |
Why?
|
| Shear Strength | 1 | 2012 | 7 | 0.090 |
Why?
|
| Logistic Models | 1 | 2012 | 196 | 0.090 |
Why?
|
| Orthopedics | 1 | 2012 | 32 | 0.090 |
Why?
|
| Child | 1 | 2013 | 614 | 0.090 |
Why?
|
| Athletic Performance | 1 | 2011 | 7 | 0.080 |
Why?
|
| Prosthesis Fitting | 1 | 2011 | 5 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 546 | 0.080 |
Why?
|
| Suture Anchors | 1 | 2011 | 39 | 0.080 |
Why?
|
| Chicago | 1 | 2012 | 453 | 0.080 |
Why?
|
| Fractures, Cartilage | 1 | 2010 | 2 | 0.080 |
Why?
|
| Poloxamer | 1 | 2010 | 3 | 0.080 |
Why?
|
| Surface-Active Agents | 1 | 2010 | 5 | 0.080 |
Why?
|
| Elbow Joint | 1 | 2011 | 52 | 0.080 |
Why?
|
| Prosthesis Implantation | 1 | 2010 | 17 | 0.080 |
Why?
|
| Zygapophyseal Joint | 1 | 2010 | 18 | 0.080 |
Why?
|
| Adolescent | 1 | 2013 | 989 | 0.080 |
Why?
|
| Musculoskeletal System | 1 | 2010 | 3 | 0.080 |
Why?
|
| Anisotropy | 1 | 2010 | 25 | 0.080 |
Why?
|
| Athletic Injuries | 1 | 2011 | 73 | 0.080 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 3 | 0.080 |
Why?
|
| Tendon Injuries | 1 | 2011 | 81 | 0.080 |
Why?
|
| Mechanical Phenomena | 2 | 2022 | 10 | 0.080 |
Why?
|
| Neurophysins | 1 | 2009 | 1 | 0.080 |
Why?
|
| Dermoscopy | 1 | 2009 | 1 | 0.080 |
Why?
|
| Vasopressins | 1 | 2009 | 5 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2009 | 26 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2009 | 29 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2010 | 42 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 68 | 0.080 |
Why?
|
| Finite Element Analysis | 2 | 2020 | 13 | 0.080 |
Why?
|
| Diskectomy | 1 | 2010 | 65 | 0.080 |
Why?
|
| Chromium Compounds | 1 | 2009 | 3 | 0.070 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2009 | 6 | 0.070 |
Why?
|
| Phosphates | 1 | 2009 | 12 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2020 | 90 | 0.070 |
Why?
|
| Lumbar Vertebrae | 1 | 2010 | 182 | 0.070 |
Why?
|
| Chromium Alloys | 2 | 2017 | 16 | 0.070 |
Why?
|
| Cross-Linking Reagents | 1 | 2007 | 6 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2006 | 89 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2012 | 1467 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2005 | 275 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2005 | 125 | 0.060 |
Why?
|
| Arthrography | 1 | 2006 | 12 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2006 | 46 | 0.060 |
Why?
|
| Orientation | 1 | 2006 | 2 | 0.060 |
Why?
|
| Foreign-Body Reaction | 1 | 2006 | 6 | 0.060 |
Why?
|
| Motion | 1 | 2005 | 11 | 0.050 |
Why?
|
| Proteins | 1 | 2005 | 33 | 0.050 |
Why?
|
| Rheology | 1 | 2004 | 1 | 0.050 |
Why?
|
| Physical Stimulation | 1 | 2004 | 4 | 0.050 |
Why?
|
| Elasticity | 1 | 2004 | 19 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 827 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2004 | 32 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2004 | 73 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2004 | 90 | 0.050 |
Why?
|
| Electrochemical Techniques | 2 | 2013 | 4 | 0.050 |
Why?
|
| Rest | 1 | 2003 | 19 | 0.050 |
Why?
|
| Calibration | 2 | 2000 | 8 | 0.050 |
Why?
|
| Carbon | 2 | 2013 | 2 | 0.040 |
Why?
|
| Disease Progression | 2 | 2013 | 290 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2021 | 7 | 0.040 |
Why?
|
| Ovariectomy | 1 | 2021 | 19 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2013 | 214 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 67 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 324 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 225 | 0.040 |
Why?
|
| Microscopy, Atomic Force | 1 | 2020 | 4 | 0.040 |
Why?
|
| Rats | 1 | 2021 | 407 | 0.040 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2000 | 2 | 0.040 |
Why?
|
| Pain | 2 | 2013 | 193 | 0.040 |
Why?
|
| Ultrasonics | 1 | 2000 | 9 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 312 | 0.040 |
Why?
|
| Foreign Bodies | 1 | 2000 | 16 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 252 | 0.040 |
Why?
|
| Absorptiometry, Photon | 2 | 2011 | 62 | 0.040 |
Why?
|
| Rotation | 1 | 2019 | 54 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2019 | 105 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 1998 | 21 | 0.030 |
Why?
|
| Software | 1 | 1998 | 26 | 0.030 |
Why?
|
| Independent Living | 1 | 2019 | 137 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1998 | 73 | 0.030 |
Why?
|
| Interleukins | 1 | 2017 | 13 | 0.030 |
Why?
|
| Hardness | 2 | 2012 | 4 | 0.030 |
Why?
|
| Exercise | 1 | 2019 | 233 | 0.030 |
Why?
|
| Molybdenum | 1 | 2016 | 10 | 0.030 |
Why?
|
| DNA | 1 | 2015 | 57 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 256 | 0.030 |
Why?
|
| Knee Injuries | 1 | 2016 | 69 | 0.030 |
Why?
|
| Posture | 2 | 2006 | 20 | 0.030 |
Why?
|
| Interferometry | 1 | 2013 | 4 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2013 | 9 | 0.030 |
Why?
|
| Adhesiveness | 1 | 2013 | 1 | 0.030 |
Why?
|
| Diffusion | 1 | 2013 | 17 | 0.030 |
Why?
|
| Water | 1 | 2013 | 21 | 0.020 |
Why?
|
| Asymptomatic Diseases | 1 | 2013 | 3 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2013 | 43 | 0.020 |
Why?
|
| Electrons | 1 | 2012 | 8 | 0.020 |
Why?
|
| Temperature | 1 | 2012 | 33 | 0.020 |
Why?
|
| Microscopy | 1 | 2012 | 9 | 0.020 |
Why?
|
| Dental Polishing | 1 | 2011 | 1 | 0.020 |
Why?
|
| Sodium Hydroxide | 1 | 2011 | 1 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2011 | 1 | 0.020 |
Why?
|
| Dielectric Spectroscopy | 1 | 2011 | 3 | 0.020 |
Why?
|
| Rupture | 1 | 2011 | 41 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2011 | 65 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 74 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Talus | 1 | 2010 | 8 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 20 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 27 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 48 | 0.020 |
Why?
|
| Wound Healing | 1 | 2010 | 55 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 75 | 0.020 |
Why?
|
| Imidazoles | 1 | 2010 | 34 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2010 | 118 | 0.020 |
Why?
|
| Pain Management | 1 | 2010 | 74 | 0.020 |
Why?
|
| Particle Size | 1 | 2009 | 18 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 22 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2010 | 211 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2010 | 246 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2007 | 8 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2006 | 1 | 0.020 |
Why?
|
| Cricetinae | 1 | 2006 | 19 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2006 | 19 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 400 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 72 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 47 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 57 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2006 | 30 | 0.010 |
Why?
|
| Polyurethanes | 1 | 2005 | 2 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2005 | 9 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2003 | 35 | 0.010 |
Why?
|